Reprogramming of CAFs to enhance immune responses, normalizing their ECM, is being investigated through the addition of vitamin D analogs (known to convert them into a quiescent state) to ICB in pancreatic cancer, and through TGFβ blockade combined with immune checkpoint inhibition in multiple tumor types (111). The gene discussed is TGFB1; the disease is neoplasm.